.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Updates in HER2+ Metastatic Breast Cancer: HER2CLIMB

EP. 1: Relapsed/Refractory HER2+ mBC: Evolving Treatment Landscape

May 18th 2020

EP. 2: Exciting Results From HER2CLIMB in HER2+ mBC

May 18th 2020

EP. 3: HER2CLIMB: Implications for Brain Metastases in HER2+ mBC

May 18th 2020

EP. 4: HER2+ mBC: Safety and Tolerability in HER2CLIMB

May 18th 2020

EP. 5: Personal Experience With the HER2CLIMB Regimen in mBC

May 18th 2020

EP. 6: HER2CLIMB: Sequencing in Metastatic Breast Cancer

May 18th 2020

EP. 7: Relapsed/Refractory HER2+ mBC: Future Treatment Landscape

May 18th 2020